Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sebnem Bektas"'
Publikováno v:
Leukemia Research Reports, Vol 19, Iss , Pp 100369- (2023)
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains an effective option for the treatment of intermediate and high-risk Acute myeloid leukemia (AML). Post-transplant lymphoproliferative disorder (PTLD) is related to the intensity o
Externí odkaz:
https://doaj.org/article/d5c7e38b232b473a8a0d08052ce48a91
An Unexpected Post-ocrelizumab Improvement in Glycaemic Control in a Patient with Multiple Sclerosis
Publikováno v:
European Medical Journal Diabetes (2022)
Ocrelizumab, a novel member of disease-modifying therapies for multiple sclerosis (MS), is a humanised monoclonal antibody against the CD20 molecule on the surface of B cells. Reports on possible effects of this molecule in MS therapy have attracted
Externí odkaz:
https://doaj.org/article/e05e179f2ea846888d9d6f55ca656a39
Autor:
Askin, Abdullah Emre, Bektas, Sebnem, Serin, Istemi, Mutlu, Yasa Gul, Aydin, Berrin Balik, Sevindik, Omur Gokmen
Publikováno v:
Indian Journal of Hematology & Blood Transfusion; Jul2024, Vol. 40 Issue 3, p527-530, 4p
Autor:
Yiğit Kaya, Süreyya, Bektas, Sebnem, Askin, Abdullah Emre, Balık Aydın, Berrin, Mutlu, Yaşa Gül, Sevindik, Ömür Gökmen
Publikováno v:
Annals of Hematology; Jun2023, Vol. 102 Issue 6, p1599-1600, 2p
Publikováno v:
Hematology Week; 5/22/2023, p369-369, 1p